Q2 2023 Earnings Call August 4, 2023 Cautionary Statement on Forward Looking Statements Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management’s intentions, plans, beliefs, expectations or forecasts for the future, including among other things: discussions of future operations, including internation ...

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2023 Earnings Conference Call August 4, 2023 8:30 AM ET Company Participants Anthony DiMeo - Head, Investor Relations Chirag Patel - Co-Founder and Co-Chief Executive Officer Chintu Patel - Co-Founder and Co- Co-Chief Executive Officer Tasos Konidaris - Chief Financial Officer Harsher Singh - Head, Biosciences Conference Call Participants Nathan Rich - Goldman Sachs Les Sulewski - Truist David Amsellem - Piper Sandler Operator Hello, everyone and welcome to the Am ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38485 Amneal Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0546926 (State or other jurisdiction ...

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2023 Earnings Conference Call May 5, 2023 8:30 AM ET Company Participants Tony DiMeo - Head-Investor Relations Chirag Patel - President & Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Tasos Konidaris - Executive Vice President, Chief Financial Officer Conference Call Participants Balaji Prasad - Barclays Chris Schott - JPMorgan David Amsellem - Piper Sandler Greg Fraser - Truist Securities Operator Hello, everyone and welcome to the Amneal P ...

amneal We make healthy possible. Q1 2023 Earnings Call May 5, 2023 AMRX LISTED NYSE 2 Cautionary Statement on Forward Looking Statements Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management's intentions, plans, beliefs, expectations or forecasts for the future, including among other things: discus ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number 001-38485 Amneal Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Dela ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Anthony DiMeo - Senior Director of Investor Relations Chirag Patel - President and Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Tasos Konidaris - Executive Vice President, Chief Financial Officer Harsher Singh - Senior Vice President, Biosciences Conference Call Participants Elliot Wilbur - Raymond James Gary Nachman - BMO Capital Markets Chris Schott - JPMorgan D ...

Amneal Pharmaceuticals Chirag Patel, Co-founder and Co-CEO 2023 JPMorgan Healthcare Conference January 10, 2023 g Cautionary Statement on Forward Looking Statements Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management's intentions, plans, beliefs, expectations or forecasts for the future, includin ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q3 2022 Earnings Conference Call November 4, 2022 8:30 AM ET Company Participants Chirag Patel - Co-Founder, Co-Chief Executive Officer Chintu Patel - Co-Founder and Co-Chief Executive Officer Anastasios Konidaris - Executive Vice President and Chief Financial Officer Harsher Singh - Senior Vice President, Biosciences Jason Daly - Senior Vice President and Chief Legal Officer Gustavo Pesquin - EVP, Specialty Conference Call Participants David Amsellem - Piper Sandl ...